Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
US FDA Bids Adieu To Allergenic Products Adcomm; Vaccines Panel To Take Over Duties
Jul 26 2024
•
By
Sue Sutter
Responsibility for allergen testing agents and treatments will shift to the FDA's vaccines panel. • Source: Shutterstock
More from US FDA Performance Tracker
More from Regulatory Trackers